Department of Chemistry and Biomolecular Sciences, University of Ottawa, 10 Marie Curie, Ottawa, ON, K1N 6N5, Canada.
Department of Bioengineering and Therapeutic Science, University of California, San Francisco, San Francisco, CA, 94158, USA.
Nat Commun. 2020 Sep 23;11(1):4808. doi: 10.1038/s41467-020-18619-x.
The creation of artificial enzymes is a key objective of computational protein design. Although de novo enzymes have been successfully designed, these exhibit low catalytic efficiencies, requiring directed evolution to improve activity. Here, we use room-temperature X-ray crystallography to study changes in the conformational ensemble during evolution of the designed Kemp eliminase HG3 (k/K 146 Ms). We observe that catalytic residues are increasingly rigidified, the active site becomes better pre-organized, and its entrance is widened. Based on these observations, we engineer HG4, an efficient biocatalyst (k/K 103,000 Ms) containing key first and second-shell mutations found during evolution. HG4 structures reveal that its active site is pre-organized and rigidified for efficient catalysis. Our results show how directed evolution circumvents challenges inherent to enzyme design by shifting conformational ensembles to favor catalytically-productive sub-states, and suggest improvements to the design methodology that incorporate ensemble modeling of crystallographic data.
人工酶的创造是计算蛋白质设计的一个关键目标。尽管已经成功设计了从头开始的酶,但这些酶的催化效率较低,需要定向进化来提高活性。在这里,我们使用室温 X 射线晶体学来研究设计的 Kemp 消除酶 HG3(k/K 146 Ms)在进化过程中构象集合的变化。我们观察到催化残基的刚性增加,活性位点变得更好地预先组织,其入口变宽。基于这些观察结果,我们设计了 HG4,这是一种高效的生物催化剂(k/K 103,000 Ms),其中包含在进化过程中发现的关键第一和第二壳层突变。HG4 的结构表明,其活性位点预先组织并刚性化,以实现高效催化。我们的结果表明,定向进化如何通过将构象集合转移到有利于催化产物亚态来规避酶设计固有的挑战,并提出了改进设计方法的建议,即将晶体学数据的集合建模纳入其中。